1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Malignancies: new trials by email Literature Review of Malignancies trials Research Report on Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies TAB006, Toripalimab - Previously Treated, Advanced, Malignancies | Phase 1 | Withdrawn | Shanghai Junshi Bioscience Co., Ltd. | 2022-03-15 | 2022-05-31 |
Neoplasms (1)
toripalimab (1)
Shanghai Junshi Bioscience Co., Ltd. (1)
Sheng Yao, PhD (1)